SABBY MANAGEMENT LLC 13D and 13G filings for Titan Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-03 4:43 pm Sale |
2021-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP |
SABBY MANAGEMENT LLC | 24,736 11.000% |
-9,327 (-27.38%) |
Filing |
| 2021-01-22 11:58 am Purchase |
2021-01-15 | 13G | Titan Pharmaceuticals, Inc. TTNP |
SABBY MANAGEMENT LLC | 34,063 11.000% |
22,685 (+199.38%) |
Filing |
| 2021-01-07 10:00 am Purchase |
2020-12-31 | 13G | Titan Pharmaceuticals, Inc. TTNP |
SABBY MANAGEMENT LLC | 11,378 11.000% |
11,378 (New Position) |
Filing |